carcinoembryonic
antigen
and
cystic
fibrosis
protein
in
blood
from
cystic
fibrosis
homozygotes
and
heterozygote
carriers
carcinoembryonic
antigen
cea
activity
was
measured
by
radioimmunoassay
in
blood
from
cystic
fibrosis
cf
homozygotes
heterozygote
carriers
of
cf
normal
healthy
controls
and
other
patient
controls
with
carcinomas
involving
gastrointestinal
organs
all
samples
were
also
screened
by
electrofocusing
for
cystic
fibrosis
protein
cfp
a
metabolic
marker
previously
shown
to
be
associated
with
the
cf
gene
significantly
increased
levels
of
cea
activity
were
found
in
all
cfp
positive
groups
however
with
one
exception
all
patient
controls
with
marked
increases
in
cea
activity
were
cfp
negative
immunodiffusion
of
perchloric
acid
extracts
of
cea
like
material
from
heterozygote
carrier
blood
indicated
that
the
cea
like
material
which
was
elevated
in
homozygotes
and
heterozygotes
for
cf
showed
only
partial
identity
with
two
separate
cea
preparations
obtained
from
colon
carcinomas
and
was
not
identical
to
either
a
b
or
o
h
blood
group
substances
this
glycoprotein
material
did
however
react
with
three
different
anti
cea
antisera
our
finding
of
an
abnormally
increased
glycoprotein
in
cystic
fibrosis
taken
together
with
previous
reports
demonstrating
abnormalities
in
the
carbohydrate
portion
of
glycoproteins
found
in
various
exocrine
secretions
in
cf
further
suggests
that
the
primary
defect
in
this
disease
is
manifested
partly
as
a
defect
in
glycoprotein
metabolism
this
defect
may
result
from
an
abnormality
in
one
or
more
of
the
glycosyltransferases
possibly
caused
by
a
more
primary
defect
in
polyamine
metabolism
